Mechanism of angiotensin II-induced arachidonic acid metabolite release in aortic smooth muscle cells: Involvement of phospholipase D

Junji Shinoda, Osamu Kozawa, Atsushi Suzuki, Yasuko Watanabe-Tomita, Yutaka Oiso, Toshihiko Uematsu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In a previous study, we have shown that angiotensin II (Ang II) activates phosphatidylcholine-hydrolyzing phospholipase D due to Ang II-induced Ca2+ influx from extracellular space in subcultured rat aortic smooth muscle cells. In the present study, we have investigated the role of phospholipase D in Ang II-induced arachidonic acid (AA) metabolite release and prostacyclin synthesis in subcultured rat aortic smooth muscle cells. Ang II significantly stimulated AA metabolite release in a concentration-dependent manner in the range between 1 nmol/l and 0.1 μmol/l. D,L-Propranolol hydrochloride (propranolol), an inhibitor of phosphatidic acid phosphohydrolase, significantly inhibited the Ang II-induced release of AA metabolites. The Ang II-induced AA metabolite release was reduced by chelating extracellular Ca2+ with EGTA. Genistein, an inhibitor of protein tyrosine kinases, significantly suppressed the Ang II-induced AA metabolite release. 1,6-Bis-(cyclohexyloximinocarbonylamino)hexane (RHC-80267), a potent and selective inhibitor of diacylglycerol lipase, significantly inhibited the Ang IT-induced AA metabolite release. Both propranolol and RHC-80267 inhibited the Ang II-induced synthesis of 6-keto-prostaglandin F(1α), a stable metabolite of prostacyclin. The synthesis was suppressed by genistein. These results strongly suggest that the AA metabolite release induced by Ang II is mediated, at least in part, through phosphatidylcholine hydrolysis by phospholipase D activation in aortic smooth muscle cells.

Original languageEnglish
Pages (from-to)207-212
Number of pages6
JournalEuropean Journal of Endocrinology
Volume136
Issue number2
DOIs
Publication statusPublished - 01-01-1997
Externally publishedYes

Fingerprint

Phospholipase D
Arachidonic Acid
Angiotensin II
Smooth Muscle Myocytes
Propranolol
Genistein
Epoprostenol
Phosphatidylcholines
Phosphatidate Phosphatase
Lipoprotein Lipase
Egtazic Acid
Extracellular Space
Prostaglandins F
Hexanes
Protein-Tyrosine Kinases
Hydrolysis

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Shinoda, Junji ; Kozawa, Osamu ; Suzuki, Atsushi ; Watanabe-Tomita, Yasuko ; Oiso, Yutaka ; Uematsu, Toshihiko. / Mechanism of angiotensin II-induced arachidonic acid metabolite release in aortic smooth muscle cells : Involvement of phospholipase D. In: European Journal of Endocrinology. 1997 ; Vol. 136, No. 2. pp. 207-212.
@article{daca0c49c87643139dd3cde05b214db1,
title = "Mechanism of angiotensin II-induced arachidonic acid metabolite release in aortic smooth muscle cells: Involvement of phospholipase D",
abstract = "In a previous study, we have shown that angiotensin II (Ang II) activates phosphatidylcholine-hydrolyzing phospholipase D due to Ang II-induced Ca2+ influx from extracellular space in subcultured rat aortic smooth muscle cells. In the present study, we have investigated the role of phospholipase D in Ang II-induced arachidonic acid (AA) metabolite release and prostacyclin synthesis in subcultured rat aortic smooth muscle cells. Ang II significantly stimulated AA metabolite release in a concentration-dependent manner in the range between 1 nmol/l and 0.1 μmol/l. D,L-Propranolol hydrochloride (propranolol), an inhibitor of phosphatidic acid phosphohydrolase, significantly inhibited the Ang II-induced release of AA metabolites. The Ang II-induced AA metabolite release was reduced by chelating extracellular Ca2+ with EGTA. Genistein, an inhibitor of protein tyrosine kinases, significantly suppressed the Ang II-induced AA metabolite release. 1,6-Bis-(cyclohexyloximinocarbonylamino)hexane (RHC-80267), a potent and selective inhibitor of diacylglycerol lipase, significantly inhibited the Ang IT-induced AA metabolite release. Both propranolol and RHC-80267 inhibited the Ang II-induced synthesis of 6-keto-prostaglandin F(1α), a stable metabolite of prostacyclin. The synthesis was suppressed by genistein. These results strongly suggest that the AA metabolite release induced by Ang II is mediated, at least in part, through phosphatidylcholine hydrolysis by phospholipase D activation in aortic smooth muscle cells.",
author = "Junji Shinoda and Osamu Kozawa and Atsushi Suzuki and Yasuko Watanabe-Tomita and Yutaka Oiso and Toshihiko Uematsu",
year = "1997",
month = "1",
day = "1",
doi = "10.1530/eje.0.1360207",
language = "English",
volume = "136",
pages = "207--212",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "2",

}

Mechanism of angiotensin II-induced arachidonic acid metabolite release in aortic smooth muscle cells : Involvement of phospholipase D. / Shinoda, Junji; Kozawa, Osamu; Suzuki, Atsushi; Watanabe-Tomita, Yasuko; Oiso, Yutaka; Uematsu, Toshihiko.

In: European Journal of Endocrinology, Vol. 136, No. 2, 01.01.1997, p. 207-212.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mechanism of angiotensin II-induced arachidonic acid metabolite release in aortic smooth muscle cells

T2 - Involvement of phospholipase D

AU - Shinoda, Junji

AU - Kozawa, Osamu

AU - Suzuki, Atsushi

AU - Watanabe-Tomita, Yasuko

AU - Oiso, Yutaka

AU - Uematsu, Toshihiko

PY - 1997/1/1

Y1 - 1997/1/1

N2 - In a previous study, we have shown that angiotensin II (Ang II) activates phosphatidylcholine-hydrolyzing phospholipase D due to Ang II-induced Ca2+ influx from extracellular space in subcultured rat aortic smooth muscle cells. In the present study, we have investigated the role of phospholipase D in Ang II-induced arachidonic acid (AA) metabolite release and prostacyclin synthesis in subcultured rat aortic smooth muscle cells. Ang II significantly stimulated AA metabolite release in a concentration-dependent manner in the range between 1 nmol/l and 0.1 μmol/l. D,L-Propranolol hydrochloride (propranolol), an inhibitor of phosphatidic acid phosphohydrolase, significantly inhibited the Ang II-induced release of AA metabolites. The Ang II-induced AA metabolite release was reduced by chelating extracellular Ca2+ with EGTA. Genistein, an inhibitor of protein tyrosine kinases, significantly suppressed the Ang II-induced AA metabolite release. 1,6-Bis-(cyclohexyloximinocarbonylamino)hexane (RHC-80267), a potent and selective inhibitor of diacylglycerol lipase, significantly inhibited the Ang IT-induced AA metabolite release. Both propranolol and RHC-80267 inhibited the Ang II-induced synthesis of 6-keto-prostaglandin F(1α), a stable metabolite of prostacyclin. The synthesis was suppressed by genistein. These results strongly suggest that the AA metabolite release induced by Ang II is mediated, at least in part, through phosphatidylcholine hydrolysis by phospholipase D activation in aortic smooth muscle cells.

AB - In a previous study, we have shown that angiotensin II (Ang II) activates phosphatidylcholine-hydrolyzing phospholipase D due to Ang II-induced Ca2+ influx from extracellular space in subcultured rat aortic smooth muscle cells. In the present study, we have investigated the role of phospholipase D in Ang II-induced arachidonic acid (AA) metabolite release and prostacyclin synthesis in subcultured rat aortic smooth muscle cells. Ang II significantly stimulated AA metabolite release in a concentration-dependent manner in the range between 1 nmol/l and 0.1 μmol/l. D,L-Propranolol hydrochloride (propranolol), an inhibitor of phosphatidic acid phosphohydrolase, significantly inhibited the Ang II-induced release of AA metabolites. The Ang II-induced AA metabolite release was reduced by chelating extracellular Ca2+ with EGTA. Genistein, an inhibitor of protein tyrosine kinases, significantly suppressed the Ang II-induced AA metabolite release. 1,6-Bis-(cyclohexyloximinocarbonylamino)hexane (RHC-80267), a potent and selective inhibitor of diacylglycerol lipase, significantly inhibited the Ang IT-induced AA metabolite release. Both propranolol and RHC-80267 inhibited the Ang II-induced synthesis of 6-keto-prostaglandin F(1α), a stable metabolite of prostacyclin. The synthesis was suppressed by genistein. These results strongly suggest that the AA metabolite release induced by Ang II is mediated, at least in part, through phosphatidylcholine hydrolysis by phospholipase D activation in aortic smooth muscle cells.

UR - http://www.scopus.com/inward/record.url?scp=0031050393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031050393&partnerID=8YFLogxK

U2 - 10.1530/eje.0.1360207

DO - 10.1530/eje.0.1360207

M3 - Article

C2 - 9116917

AN - SCOPUS:0031050393

VL - 136

SP - 207

EP - 212

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 2

ER -